According to a new report LAMEA Biosensors Market, published by KBV Research, the LAMEA Biosensors Market would witness market growth of 13.1% CAGR during the forecast period (2019-2025).
The Brazil market dominated the LAMEA Piezoelectric Biosensors Market by Country 2018, growing at a CAGR of 11.4 % during the forecast period. The Argentina market is expected to witness a CAGR of 13.1% during (2019-2025). Additionally, The UAE market is expected to witness a CAGR of 12.3% during (2019-2025).
The Point of care Testing market dominated the LAMEA Biosensors Market by End User 2018, growing at a CAGR of 12 % during the forecast period. The Home healthcare Diagnostics market is expected to witness a CAGR of 13.9% during (2019-2025). Additionally, The Others market is expected to witness highest CAGR of 21.5% during (2019-2025).
The Blood Glucose Monitoring market dominated the UAE Biosensors Market by Medical Applications Type 2018, thereby, achieving a market value of $64.7 million by 2025, growing at a CAGR of 10.5 % during the forecast period. The Cholesterol Testing market is expected to witness a CAGR of 11.6% during (2019-2025). The Pregnancy Testing market is expected to witness a CAGR of 13.1% during (2019-2025). Additionally, The Blood Gas Analyzer market is expected to witness highest CAGR of 13.9% during (2019-2025).
Full Report: https://www.kbvresearch.com/lamea-biosensors-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Danaher Corporation, ABBOTT Laboratories, Siemens AG, AgaMatrix, Inc., BAYER AG, Johnson and Johnson, LIFESENSORS, Inc., Medtronic Plc., Bio-Rad laboratories, Inc. and Analog Devices, Inc.
By Product
By Technology
By End User
By Application
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
